| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Israel | 2 | |
| #5 | Canada | 1 | |
| #6 | Mexico | 1 | |
| #7 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Acyclic or carbocyclic compounds | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Muñoz Blanco Eduardo | 6 |
| #2 | Bellido Cabello De Alba María Luz | 5 |
| #3 | Cruz Teno Cristina | 5 |
| #4 | Navarrete Rueda Carmen María | 4 |
| #5 | Appendino Giovanni | 4 |
| #6 | Munoz Blanco Eduardo | 3 |
| #7 | Bellido Cabello De Alba Maria Luz | 3 |
| #8 | Navarrete Rueda Carmen Maria | 1 |
| #9 | Rolland Alain | 1 |
| #10 | Blanco Eduardo Munoz | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020163612A1 | Formulations of cannabidiol derivatives and their use as modulators of cannabinoid receptor type 2 (cb2) | |
| WO2020120637A1 | Cannabigerol quinone acid and salts thereof | |
| EP3600274A1 | Cannabidiol derivatives as inhibitors of the hif prolyl hydroxylases activity |